Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation

Transplant Immunology

Volumn 11, Issue 3-4, 2003, Pages 345-356

  Arpinati, Mario ^a   Chirumbolo, Gabriella ^a   Urbini, Benedetta ^a   Perrone, Giulia ^a   Rondelli, Damiano ^b   Anasetti, Claudio ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Hematopoietic stem cell transplantation; Myeloid dendritic cells; Plasmacytoid dendritic cells

Indexed keywords

ALEMTUZUMAB; CORTICOSTEROID DERIVATIVE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN; THYMOCYTE ANTIBODY;

ALLOTRANSPLANTATION; APOPTOSIS; CELL FUNCTION; DENDRITIC CELL; DRUG EFFECT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; LYMPH NODE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STEADY STATE; TH1 CELL; VIRUS;

EID: 0141629819     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(03)00055-8     Document Type: Article

References (98)

1. Ferrara JL, Deeg HJ. Graft-vs.-host disease. N Engl J Med 1991;324:667-674.
2. Lenarsky C. Immune recovery after bone marrow transplantation. Curr Opin Hematol 1995;2:409-412.
3. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu Y, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
4. Shlomchick W, Couzens M, Tang Bi C, Mc Niff J, Robert M, Liu J, et al. Prevention of graft vs. host disease by inactivation of host antigen- presenting cells. Science 1999;285:412-415.
5. Zhang Y, Louboutin JP, Zhu J, Rivera AJ, Emerson SG. Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-vs.-host disease. J Clin Invest 2002;109:1335-1344.
6. Eto M, Hackstein H, Kaneko K, Nomoto K, Thomson AW. Promotion of skin graft tolerance across MHC barriers by mobilization of dendritic cells in donor hemopoietic cell infusions. J Immunol 2002;169:2390-2396.
7. Matsumoto M, Katoh Y, Nakamura Y, Shimakura Y, Hagihara M, Yabe H, et al. Injection of CD4[+] and CD8[+] cells with donor or host accessory cells induces acute graft-vs.-host disease in human skin in immunodeficient mice. Exp Hematol 2001;29:720-727.
8. Bacci A, Montagnoli C, Perruccio K, Bozza S, Graziano R, Pitzurra L, et al. Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation. J Immunol 2002;168:2904-2913.
9. Liu YJ, Kanzler H, Soumelis V, Gilliet M. Dendritic cell lineage, plasticity and cross-regulation. Nat Immunol 2001;2:585-589.
10. Hart DN. Dendritic cells: Unique leukocyte populations which control the primary immune response. Blood 1997;90:3245-3287.
11. O'Doherty U, Peng M, Gezelter S. Swiggard WJ, Betjes M, Bhardway N, et al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994;82:487-549.
12. Robinson S, Patterson S, English N, Davies D, Knight S, Reid C. Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol 1999;29:2769-2778.
13. Kohrgruber N, Halanek N, Groger M, Winter D, Rappersberger K, Schmitt-Egenolf M, et al. Survival, maturation, and function of CD11c- and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines. J Immunol 1999;163:3250-3259.
14. Szabolcs P, Avigan D, Gezelter S, et al. Dendritic cells and macrophages can mature independently from a human bone marrow-derived post CFU intermediate. Blood 1996;87:4520-4530.
15. Ito T, Inaba M, Inaba K, et al. A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. J Immunol 1999;163:1409-1419.
16. MacDonald KP, Munster DJ, Clark GJ, Dzionek A, Schmitz J, Hart DN. Characterization of human blood dendritic cell subsets. Blood 2002;100:4512-4520.
17. Grouard G, Rossoan MC, Filgueira L, Durand I, Banchereau J, Liu Y. The enigmatic plasmacytoid T cells develop into dendritic cells with IL-3 and CD40-ligand. J Exp Med 1997;185:1101-1111.
18. Olweus J, BitMansour A, Warnke R, et al. Dendritic cell ontogeny: A human dendritic cell lineage of myeloid origin. PNAS 1997;94:12551-12556.
19. Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999;5:919-923.
20. Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40 ligand drive a potent Th1 polarization. Nat Immunol 2001;5:305-310.
21. Dzionek A, Fuchs A, Petra S, Cremer S, Zysk M, Miltenyi S, et al. BDCA-2, BDCA-3, and BDCA-4: Three markers for distinct dendritic subsets of dendritic cells in human peripheral blood. J Immunol 2000;165:6037.
22. Bruno L, Res P, Dessing M, Cella M, Spits H. Identification of a committed T cell precursor population in adult peripheral blood. J Exp Med 1997;185:875-884.
23. Res P, Couwenberg F, Vyth-Dreese F, Spits H. Expression of pTα mRNA in a committed dendritic cell precursors in the human thymus. Blood 1999;94:2647-2657.
24. Spits H, Couwenberg F, Bakker A, Weijer K, Uittenbogaart CH. Id2 and Id3 Inhibit Development of CD34+ Stem Cells into Predendritic Cell [Pre-DC]2 but not into pre-DC1: Evidence for a lymphoid origin of pre-DC2. J Exp Med 2000;192:1775-1783.
25. Schotte R, Rissoan MC, Bendriss-Vermare N, et al. The transcription factor spi-B is expressed in plasmacytoid DC precursors and inhibits T, B and NK cell development. Blood 2003;101:1015-1023.
26. Blom B, Ho S, Antonenko S, Liu YJ. Generation of interferon α-producing predendritic cell [pre-DC]2 from human CD34+ hematopoietic stem cells. J Exp Med 2000;192:1785-1795.
27. Briere F, Bendriss-Vermare N, Delale T, et al. Origin and filiation of human plasmacytoid dendritic cells. Hum Immunol 2002;63:1081-1093.
28. Blom B, Ligthart JWC, Schotte R, Spits H. Developmental origin of pre-DC2.
29. + and mature interdigitating dendritic cells. J Clin Invest 2001;107:835-844.
30. Vandenabeele S, Hochrein H, Mavaddat N, Winkel K, Shortman K. Human thymus contains 2 distinct dendritic cell populations. Blood 2001;97:1733-1741.
31. Penna G, Sozzani S, Adorini L. Cutting edge: Selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol 2001;167:1862-1866.
32. Jahnsen FL, Lund-Johanssen F, Dunne JF, Farkas L, Haye R, Brandtzaeg P. Experimentally induced recruitment of plasmacytoid [CD123high] dendritic cells in human nasal allergy. J Immunol 2000;165:4062-4070.
33. Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL. Plasmacytoid dendritic cells [natural interferon-α/β-producing cells] accumulate in cutaneous lupus erythematosus lesions. Am J Pathol 2001;159:237-243.
34. Bjorck P. Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood 2001;98:3520.
35. + cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J Exp Med 2001;194:1171.
36. Asselin-Paturel C, Boonstra A, Dalod M, et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2001;2:1144-1150.
37. O'Keefe M, Hochrein H, Vremec D, et al. Dendritic cell precursor populations of mouse blood: Identification of the murine homologues of human blood plasmacytoid pre-DC2 and CD11c+ DC1 precursors. Blood 2003;101:1453-1459.
38. + T cell anergy by peripheral blood DC2 precursors. Eur J Immunol 2000;31:2547-2557.
39. Kuwana M. Induction of anergic and regulatory T cells by plasmacytoid dendritic cells and other dendritic cell subsets. Hum Immunol 2002;63:1156-1163.
40. Rissoan M, Soumelis V, Kadowaki N, Grouard G, Briere F, De Waal Malefyt R, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999;283:1183-1186.
41. Arpinati M, Green C, Heimfeld S, Heuser J, Anasetti C. Granulocyte-colony stimulating factor mobilizers T helper 2-inducing dendritic cells. Blood 2000;95:2484-2490.
42. Gilliet M, Liu Y. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 2002;195:695.
43. Kadowaki N, Antonenko S, Lau Y, Liu Y. Natural interferon α/β-producing cells link innate and adaptive immunity. J Exp Med 2000;192:219.
44. Gilliet M, Liu YJ. Human plasmacytoid-derived dendritic cells and the induction of T-regulatory cells. Hum Immunol 2002;63:1149-1155.
45. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999;284:1835-1837.
46. Yonezawa A, Morita R, Takaori-Kondo A, Kadowaki N, Kitawaki T, Hori T, et al. Natural alpha interferon-producing cells respond to human immunodeficiency virus type 1 with alpha interferon production and maturation into dendritic cells. J Virol 2003;77:3777-3784.
47. Bauer M, Redecke V, Ellwart JW, et al. Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells. J Immunol 2001;166:5000-5007.
48. Kadowaki N, Antonenko S, Liu YJ. Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded RNA, respectively, stimulate CD11c- type 2 dendritic cell precursors and CD11c+ dendritic cells to produce type I IFN. J Immunol 2001;166:2291-2295.
49. Rothenfusser S, Tuma E, Endres S, Hartmann G. Plasmacytoid dendritic cells: The key to CpG[1]. Hum Immunol 2000;63:1111-1119.
50. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001;194:863-869.
51. Ito T, Amakawa R, Fukuhara S. Role of toll-like receptors in natural interferon-producing cells as sensors in immune surveillance. Hum Immunol 2002;63:1120-1125.
52. Fonteneau JF, Gilliet M, Larsson M, Dasilva I, Munz C, Liu YJ, Bhardwaj N. Activation of influenza virus-specific CD4+ and CD8+ T cells: A new role for plasmacytoid dendritic cells in adaptive immunity. Blood 2003 (in press).
53. Dalod M, Salazar-Mather TP, Malmgaard L, et al. Interferon alpha/beta and interleukin 12 responses to viral infections: Pathways regulating dendritic cell cytokine expression in vivo. J Exp Med 2002;195:517-528.
54. Charbonnier AS, Hammad H, Gosset P, et al. Derpulsed myeloid and plasmacytoid dendritic cells from house dust mite-sensitized allergic patients dysregulate the T cell response. J Leukoc Biol 2003;73:91-99.
55. Borras F, Matthews N, Lowdell M, Navarrete C. Identification of both myeloid CD11c+ and lymphoid CD11c- dendritic cell subsets in cord blood. Br J Haematol 2001;113:925-931.
56. bright dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation. Blood 2001;97:2948-2956.
57. Klangsinsirikul P, Russell N. Peripheral blood stem cell harvests from G-CSF-stimulated donors contain a skewed TH2 CD4 phenotype and a predominance of type2 dendritic cells. Exp Hematol 2002;30:495-501.
58. Soumelis V, Scott I, Gheyas F, Bouhour D, Cozon G, Cotte L, et al. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood 2001;98:906-914.
59. Arpinati M, Chirumbolo G, Urbini B, Martelli V, Stanzani M, Falcioni S, et al. Use of anti-BDCA-2 antibody for detection of dendritic cells type-2 [DC2] in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2002;29:887-891.
60. Pulendran B, Banchereau J, Burkeholder S, et al. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J Immunol 2000;165:566-572.
61. Sloand E, Kim S, Maciejewski J, Van Rhee F, Chaudhuri A, Barrett J, et al. Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood 2000;95:2269-2274.
62. Fowler DH, Kurasawa K, Smith R, Eckhaus MA, Gress RE. Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-vs.-host disease without impairing allogeneic engraftment in sublethally irradiated mice. Blood 1994;84:3540-3549.
63. Pan L, Delmonte J, Jalonen C, Ferrara J. Pretreatment of donor mice with granulocyte-colony stimulating factor polarizes T-lymphocytes towards type-2 cytokine production and reduced severity of experimental graft-vs.-host disease. Blood 1995;86:4422-4429.
64. Korbling M, Anderlini P. Peripheral blood stem cell vs. bone marrow allotransplantation: Does the source of hematopoietic stem cells matter? Blood 2001;98:2900-2908.
65. Liu YJ, Blom B. Introduction: TH2-inducing DC2 for immunotherapy. Blood 2000;95:2482.
66. Volpi I, Perruccio K, Tosti A, Capanni M, Ruggeri L, Posati S, et al. Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants. Blood 2001;97:2514-2521.
67. Rondelli D, Raspadori D, Anasetti C, Bandini G, Re F, Arpinati M, et al. Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells. Bone Marrow Transplant 1998;22:631-637.
68. Mielcarek M, Graf L, Johnson G, Torok-Storb B. Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: A mechanism for monocyte-mediated suppression of T-cell proliferation. Blood 1998;92:215-222.
69. Kitabayashi A, Hirokawa M, Hatano Y, et al. Granulocyte colony-stimulating factor down-regulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor-α production. Blood 1995;86:2220-2227.
70. Arpinati M, Chirumbolo G, Urbini B, et al. Infusion of high numbers of G-CSF mobilized blood dendritic cells type 2 [DC-2] is associated with an increased rate of chronic GVHD in allogeneic PBSC transplantation (abstract). Blood 2002;100:419a.
71. Avery S, Bollard GM, Spencer A, Schwarer AP. Type 2 dendritic cell [DC2] content in donor peripheral blood stem cell [PBSC] grafts is asssociated with improved survival following allogeneic transplantation (abstract). Blood 2002;100:138a.
72. Przepiorka D, Smith TL, Folloder J, et al. Risk factors for acute graft-vs.-host disease after allogeneic blood stem cell transplantation. Blood 1999;94:1465-1470.
73. Zaucha JM, Gooley T, Bensinger WI, et al. CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-vs.-host disease after human leukocyte antigen-identical sibling transplantation. Blood 2001;98:3221-3227.
74. Merad M, Manz MG, Karsunky H, et al. Langerhans cells renew in the skin throughout life under steady state conditions. Nat Immunol 2002;3:1135-1141.
75. Emile JF, Haddad E, Fraitag S, Canioni D, Fischer A, Brousse N. Detection of donor-derived Langerhans cells in MHC class II immunodeficient patients after allogeneic bone marrow transplantation. Br J Haematol 1997;98:480-484.
76. Krenger W, Hill GR, Ferrara JL. Cytokine cascades in acute graft-vs.-host disease. Transplantation 1997;64:553-558.
77. Cooke KR, Hill GR, Crawford JM, Bungard D, Brinson YS, Delmonte J, et al. Tumor necrosis factor-α production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-vs.-host disease. J Clin Invest 1998;120:1882-1891.
78. Reddy V. Granulocyte colony-stimulating factor mobilization alters dendritic cell cytokine production and initiates T helper 2 polarization prior to host alloantigen presentation (letter). Blood 2000;96:2635-2636.
79. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002;295:2097-2100.
80. Klangsinsirikul P, Carter GI, Byrne JL, Hale G, Russell NH. Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution. Blood 2002;99:2586-2591.
81. + dendritic cells and reduces experimental acute graft-vs.-host disease. Blood 2002;99:1825-1832.
82. Buggins AGS, Mufti GJ, Salisbury J, et al. Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab. Blood 2002;100:1715-1720.
83. Ratzinger G, Reagan JL, Heller G, Busam KJ, Young JW. Differential CD52 expression by distinct myeloid dendritic cell subsets: Implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation. Blood 2003;101:1422-1429.
84. Matyszak MK, Citterio S, Rescigno M, Ricciardi-Castagnoli P. Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur J Immunol 2000;30:1233-1242.
85. Woltman AM, De Fijter JW, Kamerling SW, Van Der Kooij SW, Paul LC, Daha MR, et al. Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages. Blood 2001;98:174-182.
86. Matasic R, Dietz AB, Vuk-Pavlovic S. Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells. J Leukoc Biol 1999;66:909-914.
87. Auffermann-Gretzinger S, Lossos IS, Vayntrub TA, et al. Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients. Blood 2002;99:1442-1448.
88. Arpinati M, Chirumbolo G, Bandini G, et al. GVHD affects DC-2 recovery after allogeneic PBSC transplantation (abstract). Bone Marrow Transplant 2002;29(Suppl. 2):P661.
89. Galy A, Rudraraju S, Baynes R, Klein J. Recovery of lymphocyte and dendritic cell subsets after autologous CD34+ cell transplantation. Bone Marrow Transplant 2000;25:1249-1255.
90. Damiani D, Stocchi R, Masolini P, et al. Dendritic cell recovery after autologous stem cell transplantation. Bone Marrow Transplant 2002;30:261-266.
91. Clark FJ, Freeman L, Dzionek A, et al. Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-vs.-host disease. Transplantation 2003;27:221-225.
92. Mohty M, Gaugler B, Faucher C, et al. Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantation. Hematology 2002;7:157-164.
93. Fearnley DB, Whyte LF, Carnoutsos SA, Cook AH, Hart DNJ. Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation. Blood 1999;93:728-736.
94. Pihusch M, Bock SH, Heller T, et al. Peripheral blood dendritic cells in patients with acute graft vs. host disease after allogeneic hematopoietic cell transplantation (abstract). Blood 2001;98:851a.
95. Zou W, Machelon V, Coulomb-L'Hermine A, et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursors dendritic cells. Nat Med 2001;12:1339-1346.
96. Gill MA, Blanco P, Arce E, Pascual V, Banchereau J, Palucka AK. Blood dendritic cells and DC-poietins in systemic lupus erythematosus. Hum Immunol 2002;63:1172-1180.
97. Shodell M, Siegal FP. Corticosteroids depress IFN-α-producing plasmacytoid dendritic cells in human blood. J Allergy Clin Immunol 2001;108:446-448.
98. Gorgun G, Miller KB, Foss FM. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-vs.-host disease. Blood 2002;100:941-947.